Widecells Group (WDC) Share Price, News & Analysis

Company Overview

WideCells Group PLC operates as an integrated stem cell support services company worldwide. It operates through three divisions: CellPlan, WideCells, and WideAcademy. The CellPlan division provides insurance products and finance solutions for the cord blood stem cell transplantation. The WideCells division offers collection, stem cell retrieval, processing, and storage services of umbilical cord blood and tissue, adipose tissue, and dental pulp under the BabyCells brand Portugal. The WideAcademy division provides research, development, education, and training programs for healthcare professionals on the collection, processing, storage, and use of stem cells; and the wider stem cell and cord blood banking and services sector. The company offers its products and services to patients, cord blood banks, and hospitals. WideCells Group PLC was founded in 2012 and is based in Manchester, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 0.29 to 0.29
• 52-Week Range: N/A
• Volume: 67.50 million shs
• Average Volume: 60.97 million shs
• Market Capitalization: £2.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WDC Stock Analysis - Frequently Asked Questions

How were Widecells Group's earnings last quarter?

Widecells Group PLC (LON:WDC) issued its quarterly earnings results on Tuesday, June, 5th. The company reported ($5.00) EPS for the quarter.

How do I buy shares of Widecells Group?

Shares of WDC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Widecells Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Widecells Group investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU).

Company Calendar

• Last Earnings: 6/05/2018
• Today: 7/19/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Care
• Sub-Industry: N/A
• Current Symbol: LON:WDC
• CIK: N/A
• Web: www.widecellsgroup.com
• Phone: 44 16 1920 7953
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.68
• Quick Ratio: 0.67

Sales & Book Value

• Annual Sales: £43.69 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.11
• Book Value: GBX (1) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 990,553,024
• Free Float: N/A
• Market Cap: £2.82 million
• Optionable: Not Optionable
• Beta: N/A